Mary Reumuth, CHIEF FINANCIAL OFFICER at Kala Pharmaceuticals, Inc. (KALA), sold 9,449 shares at $1.80 ($17K) on 2021-10-26, disclosed to the SEC on 2021-10-28.
Scheduled sale ($17k) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| KALA | SELL | 2025-06-04 | $11K | — | Filing → |
| KALA | SELL | 2025-01-07 | $13K | — | Filing → |
| KALA | SELL | 2024-06-27 | $20K | — | Filing → |